Classification of dementia and Alzheimer's disease

Acta Neurologica Scandinavica

Volumn 94, Issue SUPPL.165, 1996, Pages 41-50

  Morris, John C ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

Alzheimer's disease; Dementia; Diagnosis; Differential diagnosis

Indexed keywords

ALZHEIMER DISEASE; CONFERENCE PAPER; DEMENTIA; DISEASE CLASSIFICATION; HUMAN; HUMAN TISSUE; CLASSIFICATION; REVIEW;

ALZHEIMER DISEASE; DEMENTIA; HUMANS;

EID: 0029687051     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1996.tb05871.x     Document Type: Article

References (78)

1. Max W. The economic impact of Alzheimer's disease. Neurology 1993: 43 (Suppl 4): S6-S10.
2. Graves AB, Kukull WA. The epidemiology of dementia. In: Morris JC, ed. Handbook of dementing illnesses. New York: Marcel Dekker, 1994: 23-69.
3. Knopman D. Tacrine in Alzheimer's disease: a promising first step. Neurologist 1995: 1: 86-94.
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (DSM-IV). Washington, DC: American Psychiatric Association, 1994.
5. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984: 34: 939-44.
6. Chui HC, Victoroff JI, Margolin D., Jagust W., Shankle R., Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 1992: 42 (3 pt 1): 473-80.
7. Schoenberg BS, Anderson DW, Haerer AF. Severe dementia: prevalence and clinical features in a biracial U.S. population. Arch Neurol 1985: 42: 740-43.
8. Rocca WA, Bonaiuto S., Lippi A. et al. Prevalence of clinically diagnosed Alzheimer's disease and other dementing disorders: a door-to-door survey in Appignano, Macerata Province, Italy. Neurology 1990: 40: 626-31.
9. Petersen RC, Smith G., Kokmen E., Ivnik RJ, Tangalos EG. Memory function in normal aging. Neurology 1992: 42: 396-401.
10. Verhaeghen P., Marcoen A., Goossens L. Facts and fiction about memory aging: a quantitative integration of research findings. J Gerontol 1993: 48: P157-P171.
11. McGlone J., Gupta S., Humphrey D., Oppenheimer S., Mirsen T., Evans DR. Screening for early dementia using memory complaints from patients and relatives. Arch Neurol 1990: 47: 1189-93.
12. Bolla KI, Lindgren KN, Bonaccorsy C., Bleecker ML. Memory complaints in older adults: fact or fiction Arch Neurol 1991: 48: 61-64.
13. Koss E., Patterson MB, Ownby R., Stuckey JC, Whitehouse PJ. Memory evaluation in Alzheimer's disease: caregivers' appraisals and objective testing. Arch Neurol 1993: 50: 92-97.
14. Morris JC, McKeel DW, Jr., Storandt M. et al. Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging. Neurology 1991: 41: 469-78.
15. Tombaugh TN, McIntyre NJ. The Mini-Mental State Examination: a comprehensive review. J Am Geriatr Soc 1992: 40: 922-35.
16. Rubin EH, Storandt M., Miller JP et al. Influence of age on clinical and psychometric assessment of subjects with very mild or mild dementia of the Alzheimer type. Arch Neurol 1993: 50: 380-83.
17. Morris, JC. Evaluation of the demented patient. In: Morris JC, ed. Handbook of dementing illness. New York: Marcel Dekker, 1994: 71-87.
18. Blessed G., Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968: 114: 797-811.
19. Katzman R., Brown T., Fuld P., Peck A., Schechter R., Schimmel H. Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. Am J Psychiatry 1983: 140: 734-39.
20. Folstein MF, Folstein SE, McHugh PR. Mini-mental State: a practical method for grading the cognitive state of patients for the clinicians. J Psychiatr Res 1975: 12: 189-98.
21. Reisberg B., Ferris SH, de Leon MJ. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982: 139: 1136-39.
22. Roth M., Tym E., Mountjoy CQ et al. CAMDEX: a standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 1986: 149: 698-709.
23. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993: 43: 2412-14.
24. Alafuzoff I., Iqbal K., Friden H., Adolfsson R., Winblad B. Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis. Acta Neuropathol (Berl) 1987: 74: 209-25.
25. Wade JP, Mirsen TR, Hachinski VC et al. The clinical diagnosis of Alzheimer's disease. Arch Neurol 1987: 44: 24-29.
26. Jellinger K., Danielczyk W., Fischer P., Gabriel E. Clinicopathological analysis of dementia disorders in the elderly. J Neurol Sci 1990: 95: 239-58.
27. Berg L., Morris JC. Diagnosis. In: Terry RD, Katzman R., Bick KL, eds. Alzheimer disease. New York: Raven Press, 1994: 9-25.
28. Gearing M., Mirra SS, Hedreen JC, Sumi SM, Hansen LA, Heyman A. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology 1995: 45: 461-66.
29. Walsh JS, Welch HG, Larson EB. Survival of outpatients with Alzheimer-type dementia. Ann Intern Med 1990: 113: 429-34.
30. Clark RF, Goate AM. Molecular genetics of Alzheimer's disease. Arch Neurol 1993: 50: 1164-72.
31. Crystal HA, Dickson DW, Lizardi JE, Davies P., Wolfson LI. Antemortem diagnosis of diffuse Lewy body disease. Neurology 1990: 40: 1523-28.
32. Hansen L., Salmon D., Galasko D. et al. The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology 1990: 40: 1-8.
33. Román GC, Tatemichi TK, Erkinjuntti T. et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993: 43: 250-60.
34. McKeith IG, Fairbairn AF, Bothwell RA et al. An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology 1994: 44: 872-77.
35. Clarfield AM. The reversible dementias: do they reverse Ann Intern Med 1988: 109: 476-86.
36. Tatemichi TK, Sacktor N., Mayeux R. Dementia associated with cerebrovascular disease, other degenerative diseases, and metabolic disorders. In: Terry RD, Katzman R., Bick KL, eds. Alzheimer disease. New York: Raven Press, 1994: 123-66.
37. Hachinski VC, Iliff LD, Zilhka E. et al. Cerebral blood flow in dementia. Arch Neurol 1975: 32: 632-37.
38. Mirsen T., Hachinski V. Epidemiology and classification of vascular and multi-infarct dementia. In: Meyer JS, Lechner H., Marshall J., Toole JF, eds. Vascular and multi-infarct dementia. Mount Kisco, New York: Futura, 1988: 61-76.
39. O'Brien MD. Vascular dementia is underdiagnosed. Arch Neurol 1988: 45: 797-98.
40. Victoroff J., Mack WJ, Lyness SA, Chui HC. Multicenter clinicopathological correlation in dementia. Am J Psychiatry 1995: 152: 1476-84.
41. Yoshitake T., Kiyohara Y., Kato I., et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama study. Neurology 1995: 45: 1161-8.
42. Fischer P., Jellinger K., Gatterer G., Danielczyk W. Prospective neuropathological validationof Hachinski's ischaemic score in dementias. J Neurol Neurosurg Psychiatry 1991: 54: 580-3.
43. Stuss DT, Cummings JL. Subcortical vascular dementia. In: Cummings JL, ed. Subcortical dementia. New York: Oxford University Press, 1990: 145-63.
44. Wolfe N., Linn R., Babikian VL, Knoefel JE, Albert ML. Frontal systems impairment following multiple lacunar infarcts. Arch Neurol 1990: 47: 129-32.
45. Erkinjuntii T. Types of multi-infarct dementia. Acta Neurol Scand 1987: 75: 391-99.
46. Hershey LA, Modic MT, Jaffe DF, Greenough PG. Natural history of the vascular dementias: a prospective study of seven cases. Can J Neurol Sci 1986: 13: 559-65.
47. Lechner H., Schmidt R., Goetz B. Long-term experience of a trial in multi-infarct dementia. Neuroepidemiology 1990: 9: 228-32.
48. Mayeux R., Denaro J., Hemenegildo N. et al. A population-based investigation of Parkinson's disease with and without dementia: relationship to age and gender. Arch Neurol 1992: 49: 492-97.
49. Sutcliffe RL, Prior R., Mawby B., McQuillan WJ. Parkinson's disease in the district of the Northampton Health Authority, United Kingdom. A study of prevalence and disability. Acta Neurol Scand 1985: 72: 363-79.
50. Marder K., Flood P., Cote L., Mayeux R. A pilot study of risk factors for dementia in Parkinson's disease. Mov Disord 1990: 5: 156-61.
51. Hofman A., Schulte W., Tanja TA et al. History of dementia and Parkinson's disease in 1st-degree relatives of patients with Alzheimer's disease. Neurology 1989: 39: 1589-92.
52. Braak H., Braak E. Cognitive impairment in Parkinson's disease: amyloid plaques, neurofibrillary tangles and neuropil threads in the cerebral cortex. J Neurol Transm (P-D Sect) 1990: 2: 45-57.
53. Gibb WR, Scott T., Lees AJ. Neuronal inclusions of Parkinson's disease. Mov Disord 1991: 6: 2-11.
54. de Vos RAI, Jansen ENH, Stam FC, Ravid R., Swaab DF. Lewy bodydisease": clinicopathological correlations in 18 consecutive cases of Parkinson's disease with and without dementia. Clin Neurol Neurosurg 1995: 97: 13-22.
55. de Vos RAI, Jansen ENH, Stam FC, Ravid R., Swaab DF. Lewy body disease': clinicopathological correlations in 18 consecutive cases of Parkinson's disease with and without dementia. Clin Neurol Neurosurg 1995: 97: 13-22.
56. Rinne JO, Rummukainen J., Paljärvi L., Rinne UK. Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra. Ann Neurol 1989: 26: 47-50.
57. Mayeux R. Stern Y., Sano M., Cote L., Williams JB. Clinical and biochemical correlates of bradyphenia in Parkinson's disease. Neurology 1987: 37: 1130-34.
58. Levin BE, Liabre MM, Weiner WJ. Cognitive impairments associated with early Parkinson's disease. Neurology 1989: 39: 557-61.
59. Pillon B., Dubois B., Cusimano G., Bonnet AM, Lhermitte F., Agid Y. Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions J Neurol Neurosurg Psychiatry 1989: 52: 201-6.
60. Ferraro FR, Balota DA, Connor LT. Implicit memory and the formation of new associations in nondemented Parkinson's disease individuals and individuals with senile dementia of the Alzheimer type: a serial reaction time (SRT) investigation. Brain Cogn 1993: 21: 163-80.
61. Owen AM, James M., Leigh PN et al. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain 1992: 115 (pt 6): 1727-51.
62. Sullivan EV, Sagar HJ, Gabrieli JD, Corkin S., Growdon JH. Different cognitive profiles on standard behavioral tests in Parkinson's disease and Alzheimer's disease. J Clin Exp Neuropsychol 1989: 11: 799-820.
63. Pillon B., Dubois B., Ploska A., Agid Y. Severity and specificity of cognitive impairment in Alzheimer's, Huntington's and Parkinson's diseases and progressive supranuclear palsy. Neurology 1991: 41: 634-43.
64. Heindel WC, Salmon DP, Shults CW, Walicke PA, Butters N. Neuropsychological evidence for multiple implicit memory systems: a comparison of Alzheimer's, Huntington's, and Parkinson's disease patients. J Neurosci 1989: 9: 582-87.
65. Golbe LI, Davis PH, Schoenberg BS, Duvoisin RC. Prevalence and natural history of progressive supranuclear palsy. Neurology 1988: 38: 1031-34.
66. Podoll K., Schwarz M., Noth J. Language functions in progressive supranuclear palsy. Brain 1991: 114 (pt 3): 1457-72.
67. Ghika J., Tennis M., Hoffman E., Schoenfeld D., Growdon J. Idazoxan treatment in progressive supranuclear palsy. Neurology 1991: 41: 986-91.
68. Harper PS. The epidemiology of Huntington's disease. Hum Genet 1992: 89: 365-76.
69. Brandt J., Corwin J., Krafft L. Is verbal recognition memory really different in Huntington's and Alzheimer's disease J Clin Exp Neuropsychol 1992: 14: 773-84.
70. Hodges JR, Salmon DP, Butters N. Differential impairment of semantic and episodic memory in Alzheimer's and Huntington's diseases: a controlled prospective study. J Neurol Neurosurg Psychiatry 1990: 53: 1089-95.
71. Heindel WC, Butters N., Salmon DP. Impaired learning of a motor skill in patients with Huntington's disease. Behav Neurosci 1988: 102: 141-47.
72. Heindel WC, Salmon DP, Butters N. The biasing of weight judgments in Alzheimer's and Huntington's disease: a priming or programming phenomenon. J Clin Exp Neuropsychol 1991: 13: 189-203.
73. Hansen LA. Pathology of the other dementias. In: Terry RD, Katzman R., Bick KL, eds. Alzheimer disease. New York: Raven Press, 1994: 167-77.
74. Mendez MF, Selwood A., Mastri AR, Frey II WH. Pick's disease versus Alzheimer's disease: a comparison of clinical characteristics. Neurology 1993: 43: 289-92.
75. CJD in the nervous system. Brain Pathol 1995: 5: 33-41.
76. Brown P. Infectious cerebral amyloidoses: Creutzfeldt-Jakob disease and the Gerstmann-Sträussler-Scheinker syndrome. In: Morris JC, ed. Handbook of dementing illnesses. New York: Marcel Dekker, 1994: 353-75.
77. Budka H., Aguzzi A., Brown P., et al. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (Prion diseases). Brain Pathol 1995: 5: 459-66.
78. Friedland RP. Alzheimer's disease: clinical features and differential diagnosis. Neurology 1993: 43: S45-51.